The significance of low DBP in US adults with isolated systolic hypertension

Journal of Hypertension

Volumn 29, Issue 6, 2011, Pages 1101-1108

  Franklin, Stanley S ^a   Chow, Vincent H ^a   Mori, Alessandro D ^b   Wong, Nathan D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Forest Research Laboratories   (United States)

Author keywords

cardiovascular disease; epidemiology; hypertension; population science; risk factors

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPOTENSION; ISOLATED SYSTOLIC HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC HYPERTENSION; UNITED STATES;

EID: 79955639122     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328346a599     Document Type: Article

References (21)

1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988- 1991. Hypertension 1995; 25:305-311.
2. Franklin SS, Jacobs MJ, Wong ND, L'Italien G, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US Hypertensives: analysis based on NHANES III. Hypertension 2001; 37:869-874. (Pubitemid 32221606)
3. Wong ND, Lopez VA, L'Italien G, Chen R, Kline S, Franklin SS. High prevalence and treatment rates, but inadequate control of hypertension in U.S. persons in 2003-2004 with cardiovascular disease comorbidities. Arch Intern Med 2007; 167:2437-2442.
4. Franklin SS, Lopez VA, Wong ND, Mitchell GF, Larson MG, Vasan RS, Levy D. Single versus combined blood pressure components and risk for cardiovascular disease. The Framingham Heart Study. Circulation 2009; 119:243-325.
5. Franklin SS, Pio JR, Wong ND, Larson MG, Leip EP, Vasan RS, Levy D. Predictors of new-onset diastolic and systolic hypertension. The Framingham Heart Study. Circulation 2005; 111:1121-1127. (Pubitemid 40365472)
6. Franklin SS, Barboza MG, Pio JR, Wong ND. Blood pressure categories, hypertensive subtypes, and the metabolic syndrome. J Hypertens 2006; 24:2009-2016. (Pubitemid 44371268)
7. Chirinos JA, Franklin SS, Townsend RR, Raij L. Body mass index and hypertension hemodynamic subtypes in the adult US population. Arch Intern Med 2009; 169:580-586.
8. Shah BV, Barnwell BG, Bieier GS. SUDAAN users' manual release 7.5. Cary, NC: Triangle Institute; 1997.
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2571.
10. Grundy SM, Cleeman JL, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association National Heart Lung and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752. (Pubitemid 41532612)
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D.A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
12. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. National Health and Nutrition Examination Survey Laboratory/Medical Technologists Procedures Manual. Hyattsville, MD: US Department of Health and Human Services, Center for Disease Control and Prevention; 2003-2004.
13. Wilkinson IB,Cockcroft JR. Mind the gap: pulse pressure, cardiovascular risk, and isolated systolic hypertension. Am J Hypertens 2000; 13:1315-1317.
14. Ronnback M, Fagerudd J, Forsblom C, Petterssn-Fernholm K, Reunanen A, Groop PH. Altered age-related blood pressure pattern in type 1 diabetes. Circulation 2004; 110:1076-1082. (Pubitemid 39319005)
15. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA, For the study of Osteoporotic Fractures Research Group. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Lancet 1999; 354:971-975. (Pubitemid 29438401)
16. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 2004; 89:4246-4253. (Pubitemid 39244420)
17. Cheng L-T, Gao Y-L, Gu Y, Zhang L, Bi SH, Tang W, Wang T. Stepwise increase in the prevalence of isolated systolic hypertension with stages of chronic kidney disease. Nephol Dial Transplant 2008; 23:3895-3900.
18. Foley RN. Phosphate levels and cardiovascular disease in the general population. Clin J Am Soc Nephrol 2009; 4:1136-1139.
19. McEniery CM, McDonnell BJ, So A, Aitken S, Bolton CE, Munnery M, et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension 2009; 53:524-531.
20. Franklin SS. Isolated systolic hypertension and the J-curve of cardiovascular disease risk. Artery Res 2010; 4:1-6.
21. Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005; 45:907-913. (Pubitemid 40628936)